Delivery Order SPE2DB20D2014-SPE2DB25FC56V
- Not listed
- The Defense Logistics Agency awarded a $11,502.77 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Jardiance 10 mg tablets (90-count package), with a completion date of June 20, 2025. This contract was competitively awarded with no set-aside designation and operates under a firm fixed-price structure. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract valued at $2,172.69. This non-competitive delivery order is one of many pharmaceutical supply transactions executed through AmerisourceBergen's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle extending through December 2026. The work will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract with a ceiling value of $11,356.86 and ultimate completion date of September 16, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) with a ceiling value of $86,831.47. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Jardiance 25 mg tablets (90-count supply). This firm fixed-price delivery order, valued at $8,515.11, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract represents a non-competitive, non-set-aside award and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count packaging) under a firm fixed-price contract valued at $5,537.03. This is a non-set-aside delivery order with an ultimate completion date of September 5, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $6,155.89. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's significantly larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $8,585.13. The order is scheduled for completion by August 15, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction and is issued as a child contract under AmerisourceBergen's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC56VDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $11,743.92, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving the federal medical procurement market, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's comprehensive pharmaceutical portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Jardiance, a diabetes management medication, exemplifies the company's role as a critical supplier within the DLA's global pharmaceutical support structure, which serves customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 7/25/25 |